These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
782 related articles for article (PubMed ID: 35874689)
1. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma. Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G Front Immunol; 2022; 13():929089. PubMed ID: 35874689 [TBL] [Abstract][Full Text] [Related]
2. A prognostic signature based on the expression profile of the ferroptosis-related long non-coding RNAs in hepatocellular carcinoma. Lin X; Yang S Adv Clin Exp Med; 2022 Oct; 31(10):1099-1109. PubMed ID: 35581934 [TBL] [Abstract][Full Text] [Related]
3. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y Front Immunol; 2021; 12():719175. PubMed ID: 34603293 [TBL] [Abstract][Full Text] [Related]
4. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma. Xu L; Zheng Q; Liu W BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323 [TBL] [Abstract][Full Text] [Related]
5. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma. Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955 [TBL] [Abstract][Full Text] [Related]
6. Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods. Xiong Y; Ouyang Y; Fang K; Sun G; Tu S; Xin W; Wei Y; Xiao W Comput Math Methods Med; 2022; 2022():4558782. PubMed ID: 35774297 [TBL] [Abstract][Full Text] [Related]
7. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
8. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
9. A ferroptosis-associated lncRNAs signature predicts the prognosis of hepatocellular carcinoma. Wang D; Zhang L; Zhang Y; Zhang Y; Xu S Medicine (Baltimore); 2022 Jul; 101(28):e29546. PubMed ID: 35839000 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
11. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma. Zhang Z; Zhang W; Wang Y; Wan T; Hu B; Li C; Ge X; Lu S Front Cell Dev Biol; 2022; 10():792676. PubMed ID: 35295858 [TBL] [Abstract][Full Text] [Related]
12. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Tang B; Zhu J; Li J; Fan K; Gao Y; Cheng S; Kong C; Zheng L; Wu F; Weng Q; Lu C; Ji J Cell Commun Signal; 2020 Oct; 18(1):174. PubMed ID: 33115468 [TBL] [Abstract][Full Text] [Related]
13. Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma. Yang X; Mei M; Yang J; Guo J; Du F; Liu S Aging (Albany NY); 2022 May; 14(9):4069-4084. PubMed ID: 35550563 [TBL] [Abstract][Full Text] [Related]
14. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma. Yan J; Zhou C; Guo K; Li Q; Wang Z J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981 [TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma: A Review. Bu F; Yin S; Guan R; Xiao Y; Zeng S; Zhao Y Medicine (Baltimore); 2022 Nov; 101(47):e31747. PubMed ID: 36451456 [TBL] [Abstract][Full Text] [Related]
16. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma. Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X Front Immunol; 2022; 13():1076045. PubMed ID: 36591279 [TBL] [Abstract][Full Text] [Related]
17. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia. Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730 [TBL] [Abstract][Full Text] [Related]
18. Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma. Fang C; Liu S; Feng K; Huang C; Zhang Y; Wang J; Lin H; Wang J; Zhong C Sci Rep; 2022 Apr; 12(1):6642. PubMed ID: 35459272 [TBL] [Abstract][Full Text] [Related]
19. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer. Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848 [TBL] [Abstract][Full Text] [Related]
20. A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma. Lian J; Zhang C; Lu H Comput Math Methods Med; 2022; 2022():6284540. PubMed ID: 36035299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]